Bi Ren
North Sichuan Medical University(CN)Nanchong Central Hospital(CN)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, Head and Neck Cancer Studies, Lung Cancer Treatments and Mutations, Cancer-related molecular mechanisms research, Lung Cancer Research Studies
Most-Cited Works
- → Azvudine and nirmatrelvir–ritonavir in hospitalized patients with moderate‐to‐severe COVID‐19: Emulation of a randomized target trial(2023)12 cited
- → Are PD-1 inhibitors effective for recurrent/metastatic nasopharyngeal carcinoma? Meta-analysis and systematic review(2023)7 cited
- → Azvudine and Nirmatrelvir–Ritonavir in Hospitalised Patients with Moderate–To–Severe COVID–19: Emulation of a Randomised Target Trial(2023)3 cited
- → Comparison Efficacy and Safety of Gemcitabine plus Cisplatin and 5-Fluorouracil plus Cisplatin for Metastatic Nasopharyngeal Carcinoma: A Meta-Analysis and Systematic Review(2022)1 cited
- → CHMP4C promotes the progression and cisplatin resistance of non-small cell lung cancer via the PI3K/AKT signaling pathway(2023)
- → CHMP4C deletion inhibits the proliferation and metastasis of hypopharyngeal squamous cell carcinoma through the Wnt/β-catenin/EMT signaling pathway(2025)
- → Developing a multi-institutional nomogram for assessing lung cancer risk in patients with 5–30 mm pulmonary nodules: a retrospective analysis(2023)
- → Revealing the prognostic landscape of hemoglobin, albumin, lymphocyte and platelet score in patients with lung cancer: a meta-analysis(2024)
- → SNRPE is Associated with ERK/mTOR Signaling Activation and Reduced Autophagy to Promote Lung Adenocarcinoma Cell Proliferation(2025)